Language selection

Government of Canada / Gouvernement du Canada

Search

COVID-19 vaccination in Canada

Doses distributed Doses administered Vaccination coverage Understand the data

Older versions of this report are available on the archived reports page.

Vaccination coverage

This page provides information on the number and percentage of people that have received a COVID-19 vaccine in Canada by province or territory, vaccination status, sex, age group, and vaccine series.

We update this information every 4 weeks on Fridays at noon ET with data up to and including the previous Sunday.

This report was last updated on with data up to and including MMM DD, YYYY.

On this page

Key updates

At least 1 dose

Total population

()

5 years and older

()

0 to 4 years

()
Primary series completed

Total population

()

5 years and older

()

0 to 4 years

()
In last 6 months, primary series completed
or booster dose received

Total population

()

5 years and older

()
Booster dose received
since {{DATE}}

Total population

()

5 years and older

()

About COVID-19 vaccination and approved vaccines

About COVID-19 vaccination and approved vaccines

Vaccination programs

  • COVID-19 vaccination began in Canada on December 14, 2020.
  • You’re currently eligible for COVID-19 vaccination if you’re 6 months of age or older and you don’t have contraindications to the vaccine.
  • The National Advisory Committee on Immunization (NACI) issues statements with recommendations on the use of COVID-19 vaccines. Briefly, NACI recommends:
    • a complete primary vaccine series to provide protection against COVID-19
    • booster doses after completing the primary series to restore or improve protection against COVID-19. Please refer to the COVID-19 vaccine chapter of the Canadian Immunization Guide for more details on:
      • booster eligibility
      • timing of a booster dose
      • recommended products
  • Consistent with NACI’s Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program, NACI recommends a COVID-19 vaccine booster 6 months after your last COVID-19 vaccine dose or SARS-CoV-2 infection.
    • A booster dose should be offered to people at increased risk of severe illness from COVID-19, no matter how many booster doses they’ve already had.
    • A booster may be offered to all others aged 12 to 64, no matter how many booster doses they’ve already had.

Approved vaccines

Vaccines authorized for use for primary vaccine series in Canada currently include:

3-dose vaccines

2-dose vaccines

1-dose vaccine

Vaccines currently authorized for use as booster doses in Canada include:

  • Pfizer-BioNTech Comirnaty
    • Pfizer-BioNTech Comirnaty for ages 5 to 11 years and 16 and older
    • Pfizer-BioNTech Comirnaty Bivalent:
      • Original and Omicron BA.4/BA.5 for ages 5 and older, and
      • Original and Omicron BA.1 for ages 12 and older
  • Moderna Spikevax
    • Moderna Spikevax for ages 18 and older
    • Moderna Spikevax Bivalent for ages 18 and older:
      • Original and Omicron BA.4/BA.5, and
      • Original and Omicron BA.1
  • Novavax Nuvaxovid for ages 18 and older

Vaccination status definitions

Primary series

In this report, people have ‘completed the primary series’ (referred as ‘fully vaccinated’ in previous reports) once they’ve received all vaccine doses in the series. The number of doses depends on the specific vaccine product. Booster doses are not part of the primary series.

For 3-dose vaccine (Pfizer-BioNTech Comirnaty ages 6 months to 4 years):
  • people who have had only 1 or 2 doses are partially vaccinated
  • people who have had 3 doses have completed their primary vaccine series
For 2-dose vaccines:
  • people who have had only 1 dose are partially vaccinated.
  • people who have had both doses have completed their primary vaccine series (referred to as ‘fully vaccinated’ in previous reports).
  • moderately to severely immunocompromised people who have had both doses plus additional dose of an mRNA vaccine have completed their primary vaccine series.
For 1-dose vaccine (Janssen Jcovden):
  • people who have had only 1 dose have completed their primary vaccine series.
  • moderately to severely immunocompromised people who have had 1 dose plus additional dose of an mRNA vaccine have completed their primary vaccine series.

Booster doses

Doses after the primary series is completed are defined as ‘booster doses’ in this report (referred to as ‘additional doses’ in previous reports). Please note that this category may include doses given for the following reasons:

  • as a booster dose
  • to complete a primary series (for moderately to severely immunocompromised people)
  • for travel purposes
  • to complete a series where the recipient only received vaccines not approved by Health Canada

Local information

For local vaccination coverage data, please see your province’s or territory’s COVID-19 vaccination website.

National vaccination coverage Access and download the national vaccination coverage data over time in .csv format

Vaccination coverage is high in Canada, with [prop_atleast1dose] of the population vaccinated with at least 1 dose.

Figure 1. of who have received of a COVID-19 vaccine in Canada by jurisdiction, MMM DD, YYYY

Hover over or select a portion of the map to see the cumulative number or percent of people vaccinated in Canada and each jurisdiction over time.

The {{Cumulative number of people / Cumulative percent of the population}} who have received at least 1 dose of a COVID-19 vaccine in Canada was {1 000 / 0.1%} as of MMM DD, YYYY.
Access and download the national vaccination coverage data over time in .csv format

For local vaccination coverage data, please see your province’s or territory’s COVID-19 vaccination website.

Cumulative number and percent of people who have received a COVID-19 vaccine in Canada by vaccination status and jurisdiction, MMM DD, YYYY

Figure 1: Text description
Week ending Jurisdiction Age group Cumulative number of people who have received at least 1 dose Cumulative number of people who have completed the primary series Cumulative number of people who, in the last months, have completed the primary series or received a booster dose Cumulative percent of people who have received at least 1 dose Cumulative percent of people who have completed the primary series Cumulative percent of people who, in the last months, have completed the primary series or received a booster dose

Figure 2. Percent of who have in the last 6 months, completed the primary series or received a booster dose of a COVID-19 vaccine in Canada by jurisdiction, MMM DD, YYYY

Percent of people who have, in the last 6 months, completed the primary series or received a booster dose of a COVID-19 vaccine in Canada by jurisdiction, MMM DD, YYYY

Figure 2: Text description
Week ending Jurisdiction Age group Percent of people who have, in the last 6 months, completed the primary series or received a booster dose

Vaccination coverage by age, sex, and province or territory

For more information on the vaccination status listed in Table 1 and 2, please refer to the Vaccination coverage: Definitions.

Table 1. Cumulative number and percent of people in Canada who have received a COVID-19 vaccine by sex and vaccination status, MMM DD, YYYY

Sex At least 1 dose Primary series completed In the last 6 months, primary series completed or booster dose received
Females () () ()
Males () () ()

Table 2. Cumulative number and percent of people in Canada who have received a COVID-19 vaccine by age group and vaccination status, MMM DD, YYYY

Age group (years) At least 1 dose Primary series completed In the last 6 months, primary series completed or booster dose received
Notes

Figure 3. of people who have received of a COVID-19 vaccine in by age group and sex, MMM DD, YYYY Access and download the vaccination coverage by age, sex, and province/territory data over time in .csv format

Hover over or select a bar to see the cumulative number or percent of people vaccinated so far.

Figure 3: Text description

Cumulative number and percent of people who have received a COVID-19 vaccine in Canada by vaccination status, age group, sex, and jurisdiction, MMM DD, YYYY

Jurisdiction Sex Age group Cumulative number of people who have received at least 1 dose Cumulative number of people who have completed the primary series Cumulative number of people who, in the last 6 months, have completed the primary series or received a booster dose Cumulative percent of people who have received at least 1 dose Cumulative percent of people who have completed the primary series Cumulative percent of people who, in the last 6 months, have completed the primary series or received a booster dose

Figure 4. of who have received of a COVID-19 vaccine in by age group and report week, MMM DD, YYYY Access and download the vaccination coverage by age, sex, and province/territory data over time in .csv format

Hover over or select a portion of the line graph to see the cumulative number or percent of people vaccinated by age group and report week. Click on a legend element to add or remove the corresponding lines from the graph.

*The reporting frequency changed from every week to every 2 weeks after April 10, 2022 and every 4 weeks after May 22, 2022.

Cumulative number and percent of people who have received a COVID-19 vaccine in Canada by vaccination status, age group, sex, and jurisdiction, MMM DD, YYYY

Figure 4: Text description
Jurisdiction Sex Age group Cumulative number of people who have received at least 1 dose Cumulative number of people who have completed the primary series Cumulative number of people who have received a 1st booster dose Cumulative number of people who have received a 2nd booster dose Cumulative percent of people who have received at least 1 dose Cumulative percent of people who have completed the primary series Cumulative percent of people who have received a 1st booster dose Cumulative percent of people who have received a 2nd booster dose

Vaccination coverage by vaccine series

People in Canada have received a variety of vaccine series, the most common of which is the series containing only the Pfizer-BioNTech Comirnaty vaccine.

For more information on the vaccine series listed in Table 3, please refer to their definitions.

Table 3. Cumulative percent and number of people who have received a COVID-19 vaccine in by vaccine series and vaccination status, MMM DD, YYYY Access and download the vaccination coverage by age, sex, and province/territory data in .csv format

Primary series schedule Vaccine included in the primary vaccine series At least 1 dose Primary series completed

Figure 5. of people who have received booster doses of a COVID-19 vaccine in by vaccine product and vaccination status, MMM DD, YYYY Access and download the cumulative number and percent of people who have received a COVID-19 vaccine by vaccine product, vaccination status, jurisdiction, and report week data in .csv format

Hover over a portion of the bar graph to see the cumulative number or percent of people vaccinated by vaccine product and vaccination status.

Figure 5: Text description

Cumulative number and percent of people who have received a COVID-19 vaccine by vaccine product, vaccination status, jurisdiction, and report week, MMM DD, YYYY

Week ending Jurisdiction Vaccine Cumulative number of people who have received a 1st booster dose Cumulative number of people who have received a 2nd booster dose Cumulative percent of people who have received a 1st booster dose Cumulative percent of people who have received a 2nd booster dose

Acknowledgements

This report would not be possible without the collaboration of provincial and territorial public health partners as well as members of the Pan-Canadian Public Health Network’s Canadian Immunization Registries and Coverage Network (CIRC). We would like to thank everyone taking part in the COVID-19 vaccination rollout in Canada.

Suggested citation

Public Health Agency of Canada. Canadian COVID-19 vaccination coverage report. Ottawa: Public Health Agency of Canada; January 22, 2021. https://health-infobase.canada.ca/covid-19/vaccination-coverage/

Related links

For health professionals

Top of page

Did you find what you were looking for?

What was wrong?

Answers to frequently asked questions can be found in the Understanding the data section!

(Don’t include any personal information. Note that you will not receive a reply.)
Maximum 300 characters

Thank you for your feedback

Date modified: